FDA inspection
Hans Biomed Corporation: FDA inspection ending Sep 12, 2025
FDA inspection 1282278 · Voluntary Action Indicated (VAI) · Yuseong District
Key facts
| Inspection ID | 1282278 |
|---|---|
| Firm | Hans Biomed Corporation |
| FEI number | 3003828812 |
| Address | 64 Yuseong-Daero 1628 Beon-Gil |
| City | Yuseong District |
| Country | Korea (the Republic of) |
| Fiscal year | 2025 |
| Inspection end date | Sep 12, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data